Belgium-based Mithra Pharmaceuticals has launched the Mithra Campus at an event held in Mumbai today.  The state of the art campus will provide an innovative and regulatory platform that will enable and facilitate increased presence and access to the European market for Indian pharmaceutical companies. The company aspires to create new synergies through cross fertilization of R&D ideas and commercial exchanges via this platform.

The Campus will provide a research & development and regulatory platform for Indian pharmaceutical companies to come together and co-create healthcare and pharmaceutical products of the future. The Campus allows a gateway for Indian pharmaceutical companies to enter the European Market.

Ashish Sehgal – Business Consultant with Mithra Pharmaceuticals said. “This campus is well positioned to address the current challenges of Indian Pharmaceutical industry not only in terms of the infrastructure but also the collaborative eco-system. Above all, this campus acts as the access point for Indian pharmaceutical companies to enter the European market and increase their business and value proposition as a whole.”

Francois Fornieri – CEO & Founder, Mithra Pharmaceuticals said, “Mithra campus provides a great platform for pharmaceutical companies to come together and co-create and shape the future of pharmaceutical advancements.”

Lack of emphasis on research and development and higher cost of medical equipment has been the major deterrent for growth of Indian Pharmaceuticals even after huge investments. Coupled with lack of academic collaboration and disconnect between curriculums, has made it further challenging to make advances in the field.